4[6]Larrey D. Drug - induced hepatitis: epidemiologic, clinical, diagnostic and physiolathologic aspecs in 1995 [J]. RevMed Inteme. 1995, 16 (10): 752 ~758. 被引量:1
5Grieco A, forgione A, Giorgi A. Propafenone- related cholestatic hepatitis in an elderly patient. Ital Heart J, 2002,3:431 -434. 被引量:1
6Sharma SK, Balamurugan A, Saha PK. Evaluation of clinical and immunogenetic risk factors for the development of hepatotoxicity during antituberculosis treatment. Am J Respir Crit Care Med,2002,166:916 - 919. 被引量:1